PART I Overview CorMedix Inc. (collectively, with our wholly owned subsidiaries, referred to herein as we, us, our or the Company) is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. Our primary focus has been commercializing DefenCath (taurolidine and heparin), in the U.S., which we launched in 2024 in the hemodialysis setting. The name DefenCath is the U.S. proprietary name approved by the U.S. Food and Dru...
Q2 FY2026 — expected 2026-09-08
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-05 | 2025-12-31 | 0001213900-26-023889 | EDGAR | 66K words |
| 2025-03-25 | 2024-12-31 | 0001013762-25-001852 | EDGAR | — |
| 2024-03-12 | 2023-12-31 | 0001213900-24-021585 | EDGAR | — |
| 2023-03-30 | 2022-12-31 | 0001213900-23-024310 | EDGAR | — |
| 2022-03-29 | 2021-12-31 | 0001213900-22-015852 | EDGAR | — |
| 2021-03-30 | 2020-12-31 | 0001213900-21-018684 | EDGAR | — |
| 2020-03-16 | 2019-12-31 | 0001213900-20-006521 | EDGAR | — |
| 2019-03-14 | 2018-12-31 | 0001654954-19-002741 | EDGAR | — |
| 2018-03-19 | 2017-12-31 | 0001654954-18-002777 | EDGAR | — |
| 2017-03-16 | 2016-12-31 | 0001654954-17-002094 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-12 | 2025-09-30 | 0001213900-25-108777 | EDGAR | 42K words |
| 2025-08-07 | 2025-06-30 | 0001213900-25-072843 | EDGAR | — |
| 2025-05-06 | 2025-03-31 | 0001213900-25-039908 | EDGAR | — |
| 2024-10-30 | 2024-09-30 | 0001213900-24-091961 | EDGAR | — |
| 2024-08-14 | 2024-06-30 | 0001213900-24-068600 | EDGAR | — |
| 2024-05-09 | 2024-03-31 | 0001213900-24-041031 | EDGAR | — |
| 2023-11-14 | 2023-09-30 | 0001213900-23-086981 | EDGAR | — |
| 2023-08-08 | 2023-06-30 | 0001213900-23-064244 | EDGAR | — |
| 2023-05-15 | 2023-03-31 | 0001213900-23-039793 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0001213900-22-070834 | EDGAR | — |
| 2022-08-11 | 2022-06-30 | 0001213900-22-046617 | EDGAR | — |
| 2022-05-12 | 2022-03-31 | 0001213900-22-025967 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-07 | 0001410098-26-000044 | EDGAR | — |
| 2026-03-06 | 0001213900-26-024777 | EDGAR | 4K words |
| 2026-03-05 | 0001213900-26-023881 | EDGAR | — |
| 2026-01-08 | 0001213900-26-002350 | EDGAR | — |
| 2025-11-12 | 0001213900-25-108716 | EDGAR | — |
| 2025-10-20 | 0001213900-25-100156 | EDGAR | — |
| 2025-09-02 | 0001213900-25-082956 | EDGAR | — |
| 2025-08-12 | 0001213900-25-075010 | EDGAR | — |
| 2025-08-07 | 0001213900-25-072814 | EDGAR | — |
| 2025-06-30 | 0001213900-25-059702 | EDGAR | — |
384 total filings indexed. 352 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001410098 |
| Ticker | CRMD |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.cormedix.com |
| Listed | 2010-05-13 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/CRMD (~200 tokens, structured JSON with cryptographic provenance)